eli lilly’s chief scientific officer on covid antibody drug results
Published 3 years ago • 2.2K plays • Length 3:48Download video MP4
Download video MP3
Similar videos
-
5:19
watch cnbc's interview with eli lilly's chief scientific officer on the new covid-19 antibody drug
-
5:32
lilly tests covid-19 antibody drug in nursing home facilities
-
3:33
eli lilly reports results from covid-19 phase 2 antibody drug trial
-
9:22
eli lilly ceo discusses its coronavirus antibody drug and the latest on its breast cancer treatment
-
1:44
eli lilly confirms it has paused one of its covid-19 antibody tests
-
1:41
eli lilly ceo explains supply chain of covid-19 antibody drug
-
23:50
eli lilly ceo says virus will be 'endemic'
-
53:34
akiko iwasaki: "immunology: antibodies" (11/17/2020)
-
5:56
eli lilly ceo says science will win in covid fight
-
4:39
eli lilly ceo on how covid-19 antibody drug helped drive q4 earnings
-
2:13
eli lilly ceo on covid antibody treatment's effectiveness against mutations
-
2:41
eli lilly reports positive phase 3 trial results for covid antibody drug
-
1:15
eli lilly starts late-stage trial for covid-19 antibody drug in nursing homes
-
6:52
eli lilly antibody drug will reduce hospitalizations: ceo
-
4:27
jim cramer on eli lilly's covid-19 phase 2 trial results for antibody drug
-
0:39
lilly antibody drug 80% effective at preventing covid-19: nursing home study
-
2:47
eli lilly hopes to start testing coronavirus cure 'this summer': ceo
-
1:51
lilly drug cuts risk of contracting covid-19 by 80%: study
-
4:37
eli lilly ceo: covid-19 antibody treatment will help reduce hospitalizations
-
1:54
coronavirus: eli lilly launches first human trial of a new type of treatment
-
5:32
regeneron's science chief on starting clinical trials for covid-19 antibody drug
-
1:05
eli lilly files for emergency use authorization of its covid-19 antibody drug